Recovery Patterns During Extended Hyperbaric Oxygen Treatment Combined With Steroids in Severe Sudden Sensorineural Hearing Loss: A Multi-Center Study
Recovery Patterns During Extended Hyperbaric Oxygen Treatment Combined With Steroids in Severe Sudden Sensorineural Hearing Loss: A Multi-Center Study
Description
ABSTRACT
Yang W, Yang M, Yang T, Wang Z, Lin W, Pan S, Li H. Recovery Patterns During Extended Hyperbaric
Oxygen Treatment Combined With Steroids in Severe Sudden Sensorineural Hearing Loss: A Multi-
Center Study. Undersea Hyperb Med. 2026 Second Quarter; 53(2):261-270.
Introduction: Severe sudden sensorineural hearing loss (SSNHL) is a challenging otological emergency.
Hyperbaric oxygen (HBO2) treatment is an adjunctive treatment for SSNHL, improving oxygen supply and
microcirculation and reducing oxidative stress. While HBO2 is increasingly used for SSNHL, the temporal
patterns of hearing recovery during extended treatment protocols remain poorly characterized. This
study investigates the frequency-specific recovery patterns and speech recognition improvements during
a 30-session HBO2 protocol with concurrent steroid treatment in patients with severe SSNHL.
Methods: This multi-center, retrospective cohort study included patients diagnosed with severe SSNHL
at four medical centers from January 2019 to December 2024. Inclusion criteria included patients who
initiated HBO2 with steroids within five days of onset, completed 30 HBO2 sessions, and underwent
pure-tone audiometry and speech recognition assessments at specified intervals. A total of 103 patients
receiving combined HBO2 and steroid treatment were analyzed using SPSS.
Results: Low-frequency hearing (125 Hz, 250 Hz, and 500 Hz) exhibited rapid recovery, with significant
enhancements noted after ten sessions of HBO2 (P < 0.05). In contrast, mid-frequency hearing (1000
Hz and 1500 Hz) and high-frequency hearing (2000 Hz) showed notable improvements after 20 and 30
sessions (P < 0.05), with the 30-session treatment resulting in greater enhancements compared to the
20-session treatment (P < 0.05). Speech recognition rates significantly improved after 20 and 30 sessions
of HBO2 compared to pre-treatment levels (P < 0.05), with the 30-session treatment showing statistically
significantly higher rates than the ten-session HBO2 (P < 0.05).
Discussion: Hyperbaric oxygen treatment significantly enhances hearing and speech recognition in
severe SSNHL, particularly in the mid-frequency range. Long-term HBO2 treatment may be a viable option
for these patients.
Keywords: hyperbaric oxygen (HBO₂) treatment; severe sudden sensorineural hearing loss (severe
SSNHL); recovery patterns
